Innovation Pharmaceuticals Inc (IPIX)

[Chronic]

I would be surprised if Polymedix didn't have multiple CDAs with Pharmas considering PMX-30063(Brilacidin.) Any one of them could picked up the drug with pocket change once Poly went into bankruptcy. Nobody wanted this drug. And what exactly has IPIX done to move the Brilacidin forward besides tinker with the dosage?

Kevetrin has shown some encouraging signs modulating P53, but very little in the way of efficacy. Now they are going back to phase 1 once they complete their oral formulation. They started clinical trials in 2012!

Prurisol phase 2 didn't go well although the 200mg dosage showed some hope. We will find out soon how phase 2B goes, but given the lack of PRs, no interim results, and the sinking share price, it feels like there might be some bad news ahead on this front. But we don't know yet.

So where exactly will the partnership come from?